Skip to main content
SpringerLink
Log in

Impact of chronic kidney disease on clinical and angiographic results following implantation of sirolimus-eluting coronary stents

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Although sirolimus-eluting stent (SES) is effective to reduce restenosis, the effect of SES for patients with chronic kidney disease (CKD) has been ambiguous. SES were exclusively implanted into 304 lesions in 195 patients. Forty-seven percent of the patients had diabetes. Patients were divided into three groups by estimated glomerular filtration rate, CKD stage 0–2: 156 patients, 239 lesions; CKD stage 3–4: 21 patients, 37 lesions; and CKD stage 5: 18 patients, 28 lesions. Clinical follow-up data were available in 97% at 616 ± 192 days. There was a statistically significant association between the stage of CKD and target lesion revascularization (TLR) (CKD 0–2: 2.7%, CKD 3–4: 5.3%, and CKD 5: 11.9%; P = 0.011), and late lumen loss at 8 months (CKD 0–2: 0.13 ± 0.25 mm, CKD 3–4: 0.27 ± 0.47 mm, and CKD 5: 0.37 ± 0.61 mm; P = 0.0032). The frequency of clinical adverse events was also higher according to stages of CKD. In conclusion, stages of CKD proportionally correlated with TLR, late lumen loss and major adverse cardiac events following SES implantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.

    Article  CAS  PubMed  Google Scholar 

  2. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002;39:1113–9.

    Article  PubMed  Google Scholar 

  3. Hassani SE, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol. 2006;18:273–7.

    PubMed  Google Scholar 

  4. Ikari Y, Kotani J, Kozuma K, Kyo E, Nakamura M, Yokoi H. Assessment of sirolimus-eluting coronary stent implantation with aspirin plus low dose ticlopidine administration. Circ J. 2009;73:1038–44.

    Article  PubMed  Google Scholar 

  5. Kawaguchi R, Tsurugaya H, Hoshizaki H, Toyama T, Oshima S, Taniguchi K. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients. Cardiovasc Revasc Med. 2008;9:2–8.

    Article  PubMed  Google Scholar 

  6. Sasao H, Hotta D, Maeda T, Saito N, Takagi S, Shimamoto K. Comparison of long-term clinical outcome after sirolimus-eluting stent implantation in patients with and without hemodialysis. Int Heart J. 2007;48:689–700.

    Article  PubMed  Google Scholar 

  7. Nakazawa G, Tanabe K, Aoki J, Yamamoto H, Higashikuni Y, Onuma Y, et al. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv. 2007;69:808–14.

    Article  PubMed  Google Scholar 

  8. Ota T, Umeda H, Yokota S, Miyata S, Takamura A, Sugino S, et al. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation. Am Heart J. 2009;158:92–8.

    Article  CAS  PubMed  Google Scholar 

  9. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–47.

    PubMed  Google Scholar 

  10. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106:2207–11.

    Article  PubMed  Google Scholar 

  11. Athappan G, Ponniah T. Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature. Minerva Cardioangiol. 2009;57:291–7.

    CAS  PubMed  Google Scholar 

  12. Yachi S, Tanabe K, Tanimoto S, Aoki J, Nakazawa G, Yamamoto H, et al. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis. 2009;54:299–306.

    Article  PubMed  Google Scholar 

  13. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, et al. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J. 2008;72:1430–5.

    Article  PubMed  Google Scholar 

  14. Kuchulakanti PK, Torguson R, Chu WW, Canos DA, Rha SW, Clavijo L, et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2006;97:792–7.

    Article  CAS  PubMed  Google Scholar 

  15. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol. 2006;18:577–83.

    PubMed  Google Scholar 

  16. Das P, Moliterno DJ, Charnigo R, Mukherjee D, Steinhubl SR, Sneed JD, et al. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol. 2006;18:405–8.

    PubMed  Google Scholar 

  17. Latif F, Kleiman NS, Cohen DJ, Pencina MJ, Yen CH, Cutlip DE, et al. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (evaluation of drug eluting stents and ischemic events) registry. JACC Cardiovasc Interv. 2009;2:37–45.

    Article  PubMed  Google Scholar 

  18. Jeong YH, Hong MK, Lee CW, Park DW, Kim YH, Kim JJ, et al. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol. 2008;125:36–40.

    Article  PubMed  Google Scholar 

  19. Lemos PA, Arampatzis CA, Hoye A, Daemen J, Ong AT, Saia F, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol. 2005;95:167–72.

    Article  CAS  PubMed  Google Scholar 

  20. Mishkel GJ, Varghese JJ, Moore AL, Aguirre F, Markwell SJ, Shelton M. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease. J Invasive Cardiol. 2007;19:331–7.

    PubMed  Google Scholar 

  21. Islam TM, Fox CS, Mann D, Muntner P. Age-related associations of hypertension and diabetes mellitus with chronic kidney disease. BMC Nephrol. 2009;10:17.

    Article  PubMed  Google Scholar 

  22. Kuriyama N, Kobayashi Y, Nakayama T, Kuroda N, Komuro I. Images in cardiovascular medicine. Damage to polymer of a sirolimus-eluting stent. Circulation. 2006;114:e586–7.

    Article  PubMed  Google Scholar 

  23. Bocksch W, Fateh-Moghadam S, Mueller E, Huehns S, Waigand J, Dietz R. Percutaneous coronary intervention in patients with end-stage renal disease. Kidney Blood Press Res. 2005;28:275–9.

    Article  PubMed  Google Scholar 

  24. Tomiyama C, Carvalho AB, Higa A, Jorgetti V, Draibe SA, Canziani ME. Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment. J Bone Miner Res. 2010;25:499–504.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan

    Yota Kawamura, Yoshihiro Morino, Masakazu Nagaoka, Takashi Matsukage, Naoki Masuda & Yuji Ikari

Authors
  1. Yota Kawamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihiro Morino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masakazu Nagaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Matsukage
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naoki Masuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuji Ikari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuji Ikari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kawamura, Y., Morino, Y., Nagaoka, M. et al. Impact of chronic kidney disease on clinical and angiographic results following implantation of sirolimus-eluting coronary stents. Cardiovasc Interv and Ther 26, 18–25 (2011). https://doi.org/10.1007/s12928-010-0029-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-010-0029-9

Keywords

Search

Navigation